California Public Employees Retirement System’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-159,100
Closed -$280K 1554
2021
Q1
$280K Hold
159,100
﹤0.01% 3254
2020
Q4
$310K Sell
159,100
-3,300
-2% -$6.94K ﹤0.01% 3182
2020
Q3
$388K Sell
162,400
-7,933
-5% -$21.8K ﹤0.01% 2919
2020
Q2
$499K Buy
170,333
+82,150
+93% +$236K ﹤0.01% 2685
2020
Q1
$254K Hold
88,183
﹤0.01% 2739
2019
Q4
$353K Buy
+88,183
New +$384K ﹤0.01% 2885

Other funds holding ADMA

California Public Employees Retirement System's ADMA Position: Q2 2021 in Review

California Public Employees Retirement System sold out of ADMA Biologics (ADMA) in Q2 2021, closing a stake of 159,100 shares — an estimated $280K sold.

California Public Employees Retirement System first reported a position in ADMA in Q4 2019 and held it in 6 quarters. The position peaked at $499K in Q2 2020. 90 funds tracked by Wall St. Rank hold ADMA as of Q2 2021.

  • California Public Employees Retirement System reported no remaining ADMA Biologics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 159,100 ADMA Biologics shares in Q2 2021, an estimated $280K.
  • California Public Employees Retirement System first reported a position in ADMA Biologics in Q4 2019 and held it in 6 quarters.
  • California Public Employees Retirement System's ADMA Biologics position peaked at $499K in Q2 2020.
  • 90 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.